Skip Navigation


Carcinogenesis Advance Access originally published online on June 20, 2008
Carcinogenesis 2008 29(7):1415-1420; doi:10.1093/carcin/bgn144
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
29/7/1415    most recent
bgn144v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Crim, K. C.
Right arrow Articles by Lupton, J. R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crim, K. C.
Right arrow Articles by Lupton, J. R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Upregulation of p21Waf1/Cip1 expression in vivo by butyrate administration can be chemoprotective or chemopromotive depending on the lipid component of the diet

Kristy Covert Crim1,2, Lisa M. Sanders1,2, Mee Young Hong1,2,3, Stella S. Taddeo2, Nancy D. Turner1,2,3, Robert S. Chapkin1,2,3 and Joanne R. Lupton1,2,3,*

1 Faculty of Nutrition
2 Department of Nutrition and Food Science
3 Center for Environmental and Rural Health, Texas A&M University, College Station, TX 77843-2253, USA

* To whom correspondence should be addressed. Tel: +1 979 845 0850; Fax: +1 979 862 1862; Email: jlupton{at}tamu.edu

The overall goal of this research was to separate out the effects of butyrate from its fiber source and determine in vivo if it upregulates colonic histone acetylation, p21Waf1/Cip1 expression (p21) and apoptosis and if this sequela of events is protective against aberrant crypt foci (ACF) formation. Eighty Sprague-Dawley rats were provided defined diets with either corn oil or fish oil as the lipid source, ± butyrate-containing capsules targeted for release in the colon and ± azoxymethane (AOM) (10 rats per group). Diets were provided for 11 weeks and at termination colonocyte nuclear histone H4 and p21 expression were determined by immunohistochemistry, apoptosis was measured by the terminal deoxynucleotide transferase biotin-dUTP nick end labeling assay and aberrant crypt numbers and multiplicity were enumerated. Luminal butyrate levels were also quantified. AOM injection repressed p21 expression, which was reversed by butyrate supplementation. Although butyrate enhanced p21 expression with both dietary lipid sources, the increase in p21 resulted in an increase in apoptosis and decrease in ACF with fish oil, but had no effect on apoptosis and increased ACF with corn oil. This significant interaction between fat, butyrate (fiber) and p21 expression with one combination being protective and the other promotive of colon carcinogenesis reinforces the importance of considering diet as a key factor in chemoprevention.

Abbreviations: ACF, aberrant crypt foci; AOM, azoxymethane; HM-ACF, high multiplicity aberrant crypt foci; p21, p21Waf1/Cip1; SCFA, short chain fatty acids

Received October 5, 2007; revised May 19, 2008; accepted June 3, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.